These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25976920)

  • 21. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
    Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A
    Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
    Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
    Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
    J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk factors of predictive local tumor control in oral cavity cancer.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Ann Surg Oncol; 2008 Mar; 15(3):915-22. PubMed ID: 18165878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
    Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
    Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
    J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.
    Hu Q; Wu T; Chen X; Li H; Du Z; Hao Y; Peng J; Tai S; Song M; Cheng B
    Cancer Med; 2018 Apr; 7(4):1056-1069. PubMed ID: 29479858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival.
    Lu C; Lewis JS; Dupont WD; Plummer WD; Janowczyk A; Madabhushi A
    Mod Pathol; 2017 Dec; 30(12):1655-1665. PubMed ID: 28776575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
    J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Padín-Iruegas E; Gayoso-Diz P; Reis-De Almeida M; Barros-Angueira F; Gándara-Vila P; Blanco-Carrión A; García-García A
    Oncol Rep; 2014 Apr; 31(4):1677-82. PubMed ID: 24573767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A novel prognostic index for oral cancer in Fujian province].
    Wu JF; Lin LS; Chen F; Liu FQ; Yan LJ; Bao XD; Wang J; Wang R; Lin LK; Qiu Y; Zheng XY; Hu ZJ; Cai L; He BC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):841-846. PubMed ID: 29936758
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.
    Song JJ; Zhao SJ; Fang J; Ma D; Liu XQ; Chen XB; Wang Y; Cheng B; Wang Z
    BMC Cancer; 2016 Jul; 16():530. PubMed ID: 27457382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.